Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The most common ocular disease in patients with diabetes, diabetic retinopathy, is present in
approximately 40% of diabetic patients; about 8% of diabetic patients have vision threatening
diabetic retinopathy. Although intensive control of blood glucose has been shown to reduce
the development and progression of diabetic retinopathy, intensive control of glucose is
usually not achieved in clinical practice.